This study evaluated the impact of reducing the dose of abatacept (Orencia) in patients who were no longer showing any signs or symptoms of rheumatoid arthritis.

This study, recruiting in the United Kingdom, will attempt to identify certain naturally occurring body substances (biomarkers) that predict the reduction of symptoms (remission) of rheumatoid arthritis (RA). The primary outcome is to identify the biomarkers that will predict which patients will have RA remission following stopping of medication. 

The study compared survival rates in patients with early stage breast cancer treated with mastectomy versus lumpectomy plus radiation therapy.

This study examined whether adding infliximab (Remicade) to a combination of treatments improved long-term outcome in rheumatoid arthritis (RA). The study concluded that a combination of treatments resulted in disease remission and prevented the disease from getting worse. Adding infliximab did not improve remission rates. 

This article evaluates lifestyle behaviors breast cancer survivors adopt in order to lower the risk of recurrence.

This study examined the association between socioeconomic status with clinical measures in rheumatoid arthritis patients.

This study examined whether the timing of adjuvant chemotherapy affects survival among women with breast cancer.

This article reviews how etanercept (Enbrel) works and what adverse events it may cause in patients with rheumatic diseases.

In this study, researchers investigated whether high-fat dairy products are linked to breast cancer recurrence (return of the cancer) in breast cancer patients.

This study investigated the clinical effectiveness of hand exercise and joint protection sessions for adults with hand osteoarthritis.